APA (7th ed.) Citation

N, A., M, O., DA, L., A, M., M, A., B, M., . . . E, B. (2024). BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt-associated ascites in pediatric low-grade gliomas. Pediatric blood & cancer, 71(8), e31058. https://doi.org/10.1002/pbc.31058

Chicago Style (17th ed.) Citation

N, Amayiri, Obeidat M, Laban DA, Musharbash A, Al-Hussaini M, Maraqa B, Ibrahimi A, Sarhan N, and Bouffet E. "BRAF/MEK Inhibitors Use to Treat Ventriculoperitoneal Shunt-associated Ascites in Pediatric Low-grade Gliomas." Pediatric Blood & Cancer 71, no. 8 (2024): e31058. https://doi.org/10.1002/pbc.31058.

MLA (9th ed.) Citation

N, Amayiri, et al. "BRAF/MEK Inhibitors Use to Treat Ventriculoperitoneal Shunt-associated Ascites in Pediatric Low-grade Gliomas." Pediatric Blood & Cancer, vol. 71, no. 8, 2024, p. e31058, https://doi.org/10.1002/pbc.31058.